| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.007 |